Centene Corporation updated annual guidance for the year 2021. For the year, the company now expects total revenues to be in the range $120.1 billion to $122.1 billion. GAAP Diluted EPS to be in the range of $3.68 to $3.90. The Company's guidance has been updated to reflect the following: ongoing suspension of Medicaid eligibility redeterminations to August 1; the extensions of the California pharmacy services to July 1 and New York pharmacy services through 2022; the Marketplace special enrollment period; the recent Oklahoma contract awards; Medicare membership, sequestration, and the fee schedule increase; and updated expectations regarding state premium rate adjustments and risk sharing mechanisms.